Bipartisan Bill Expanding 340B Discounts To Inpatient Drugs Introduced In House
This article was originally published in The Pink Sheet Daily
Executive Summary
Bill would also repeal the ban on 340B discounts for orphan drugs purchased by rural and free-standing cancer hospitals.
You may also be interested in...
A Return To Restricted Pharmacy Networks Leaves NCPA Concerned
In an interview, National Community Pharmacists Association CEO Doug Hoey expresses concern with restricted pharmacy networks in health plans as well as a lack of clarity about those restricted networks on the Medicare Part D Plan Finder website.
GAO And Legislators Pushing HHS For Stronger 340B Oversight
The Government Accountability Office is proposing several recommendations to strengthen oversight of the 340B drug discount program, but says the HHS Health Resources and Services Administration wants to take other measures that GAO believes are insufficient.
GAO And Legislators Pushing HHS For Stronger 340B Oversight
The Government Accountability Office is proposing several recommendations to strengthen oversight of the 340B drug discount program, but says the HHS Health Resources and Services Administration wants to take other measures that GAO believes are insufficient.